Michelle Boyd

Company: Boyd Neuro Consulting (formerly Cerebral Therapeutics)

Seminars:

1.00 Applying Learnings from Successful Dose Scaling to Bring New ICV-Administered Therapies to the Clinic 1:00 pm

Reviewing different scaling methods for ICV delivery Conducting successful dose scaling across species Overcoming the challenges of scaling for intra-CSF delivery routesRead more

day: Day Two Track 2 PM

9.30 Panel Discussion | Assessing the Invasiveness of Local Administration Over Systemic Injection: Do the Risks Outweigh the Rewards? 9:30 am

Making the case that a given CNS disorder requires local delivery: Is there sufficient evidence to support the requirement for a direct RoA? How does level of invasiveness differ depending on drug modality? Are genetic medicines safer to consider for local delivery due to one-time dosing? Which brain regions hold the most promise for targeting…Read more

day: Day One